🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our work ;-)

For medical imaging PhDs/postdocs in the Netherlands, we’ve revived MISP. Check it out!

In our new preprint we introduce LIRE+ an #Equivariant & #Multiscale method for #CBCT #reconstruction! LIRE+ outperforms existing methods, including traditional LIRE, offering faster and memory-efficient CBCT reconstruction Check it out: arxiv.org/abs/2401.11256

Meet Vivein of our lab who wants to inspire more girls to pursue scientific careers

We have two papers accepted at #CVPR2024! It’s great to see that our lab is able to generate both translational and theoretical impactful research results, all for the benefit of #cancer patients.

Explainable AI? Check our new open access EJR paper

🎉𝐃𝐈𝐑𝐄𝐂𝐓 𝐯2.0.0 𝐢𝐬 𝐨𝐮𝐭! New features for #DL-based #MRI #Reconstruction including models like RecurrentVarNet & vSHARPNet, MRI transforms and losses, along with code quality upgrades and 3D data support! 🔮 Up Next: #CMRxRecon 2023, #SSL, adaptive sampling & more!

We've released v2.0.0 of our deep learning-based MRI framework; many new models and an extended model zoo!

Our latest paper - Task-Driven Wavelets Using Constrained Empirical Risk Minimization - has been accepted at CVPR for an oral presentation. Congratulations to Eric Marcus, Ray Sheombarsing and Jonas Teuwen for being in the top 3% of all the accepted papers!

linkedin.com/posts/bart-bru… Zouden jullie svp deze hartenkreet onder de aandacht willen brengen?

Excited to share that our AI for Oncology team at the Netherlands Cancer Institute will be presenting two papers related to our research at #CVPR2024 ! See you there!

🚀 Exciting news! Ellogon.AI, co-founded with Evangelos Kanoulas, recognized as a top startup by Greek co-founders, on AI and health, alongside Harvard, Oxford, ... We specialize in various cancers and immunotherapy compatibility. Stay tuned shorturl.at/CRYXl

Patiënten met uitgezaaide huidkanker hebben in de meeste gevallen baat bij immuuntherapie voor een operatie. Dit blijkt uit de resultaten van de NADINA-studie die later vandaag worden gepresenteerd door Christian Blank. Lees meer ➡️ bit.ly/3X0LZ9v

Ready to poster at #cvpr2024 Joren Brunekreef Eric Marcus AI for Oncology Lab The Netherlands Cancer Institute

Happening now at poster 376 Cees Snoek

I couldn’t be happier that my #MRI #brain scan last Friday showed no evidence of recurrence of my #glioblastoma! It’s now 13.5 months since my seizure in Poland when it showed up. I cannot thank the entire neuro-oncology team enough for looking after me & supporting me so well

Excited to share our paper on vSHARP, a sota DL-based #MRI #reconstruction method, is now published in Magnetic Resonance Imaging! Applied to CMRxRecon@MICCAI 2025 challenges, vSHARP was among the winners both years! Link: authors.elsevier.com/c/1k9fW,GdM5rW… #AI #DeepLearning George Yiasemis